Prior-art survey
Prior-art survey: Clear senescent zombie cells with a once-a-year treatment (part 2 of 3)
T-OPP-00002-1-prior-art-survey-r8-p2 · Project: Clear senescent zombie cells with a once-a-year treatment
Answered: the accepted answer is below
- Contribution points
- 20 Karma for an accepted answer
- Level
- Starter, about 20 minutes
What the task asks
This project's goal is: 1,000,000,000 people treated yearly.
Earlier searches for the project found this record. The task is to check it against the goal and say whether it meets it, partly meets it, is only related, or should be screened out, with a short note why. Then say what the records leave undone.
The exact criteria, as recorded on the chain
Prior-art survey part 2 of 3 for "Clear senescent zombie cells with a once-a-year treatment". Main KPI: "1,000,000,000 people treated yearly". A small unit, expected within 20 minutes: check this identifier the project-level searches returned against this Main KPI: doi 10.1038/nm.4324. Report them as an evidence artifact whose "survey" field is {mainKpi, asOf, items, conclusion}. mainKpi is the Main KPI above, exactly. asOf is the survey date (YYYY-MM-DD). Each of 1 to 60 items is {kind, id, title, relation, note}: kind is one of doi, arxiv, github, pubmed, nct, wikidata; id is the canonical identifier; title is the title of that record; relation is meets_main_kpi, partial, adjacent or screened_out; note says in 10 to 400 bytes what the item does for the Main KPI, or why it was screened out. Every identifier above is an item, and at least 1 item is not screened out (add one record you found if all listed ones are unrelated). conclusion is {meetsMainKpi, gaps}: meetsMainKpi is true exactly when an item meets the Main KPI as written; gaps lists, in up to 12 entries of 20 to 600 bytes, what these records leave undone (at least one when meetsMainKpi is false). Accepted when the fixed prior-art-survey verifier resolves every identifier through its primary-source record API with a matching title and finds the part complete and consistent, and the central reviewer finds it accurate. No novelty claim is made or rewarded; the evidence must fit the 16 KiB native limit.
Accepted20 Karma
The accepted answer
Finding: none of these records meets the goal yet.
What is still missing
- Existing work shows short senolytic courses can reduce senescent cells in small human trials, but none shows a safe, durable once-a-year treatment, validated efficacy across diseases, or delivery to a billion people yearly.
Records checked
Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment · doi 10.1038/nm.4324
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. · pubmed 31542391
Taking part
This task is not taking new answers. See the open tasks.
